
We are acting on our purpose to defeat serious chronic diseases by expanding our commitment in areas of high unmet need, including metabolic dysfunction-associated steatohepatitis (MASH). This is a disease that impacts a growing number of people worldwide, and we welcome you to learn more about its causes, symptoms, and how to improve liver health, while also discovering our research and development efforts to help address the unmet medical need in this disease area.
We are committed to driving change to improve treatment options for people living with type 2 and Type 1 diabetes – from more effective medicines to take care of their diabetic complications that make management simpler and more convenient.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.